Phase 4 Obesity Trial, Recruiting NCT06620562 Sponsor: Laval University Condition: Obesity
Back to Obesity

Phase 4 Obesity Trial, Recruiting

NCT06620562
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Your body mass index (BMI) is above 30 kg/m² and you have at least one health condition related to your weight (such as diabetes or high blood pressure), OR your BMI is above 35 kg/m² even without any weight-related health conditions

Who may not be able to join:

  • You have previously had weight loss surgery and would be having a second or follow-up operation
  • You are currently pregnant or planning to become pregnant within the next 24 months
  • You are currently taking any other medications to help with weight loss
  • You have high blood pressure that is not well controlled by treatment
  • You currently use opioid (strong painkiller) medications on a regular basis, or take medications like methadone or buprenorphine, or are going through opioid withdrawal
  • You are currently taking any other medication that contains bupropion (an ingredient also used in some antidepressants and stop-smoking aids)
  • You are taking a type of antidepressant called a monoamine oxidase inhibitor (MAOI) (confirm with trial site)
  • You have severe, end-stage liver or kidney disease
  • You are taking blood-thinning or antiplatelet medications called ticlopidine or clopidogrel (confirm with trial site)
  • You are taking an antipsychotic medication called thioridazine
  • You have epilepsy or have ever had a seizure
  • You have a cardiac pacemaker fitted
  • You currently have or have previously been diagnosed with an eating disorder such as bulimia nervosa or anorexia nervosa

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Phone: 4186568711

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Sponsor
Laval University
Registry
ClinicalTrials.gov
Start date
4 June 2025
Est. completion
1 June 2028

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Weight loss; Percentage of participant with an Excess Weight Loss above 50%

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov